Indeed, intestinal inflammation increases during obesity and is negatively correlated with the expression of AhR and IL-22 genes [193], whereas treatment with AhR agonists restores the tight junctions of intestinal epithelial damaged by palm oil feeding and improves intestinal inflammation [193]. The gene discussed is AHR; the disease is obesity due to melanocortin 4 receptor deficiency.